AADI BIOSCIENCE Trademark

Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Vaccine preparations; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of vascular malformations; Pharmaceutical preparations for the prevention and treatment of vascular system related diseases and disorders; Pharmaceutical preparations for use in plastic surgery; Pharmaceutical preparations for the treatment of tissue overgrowth related diseases and disorders; Pharmaceutical preparations for the treatment of vascular anomalies